MedTrace Logo

RIAPRE - Non-interventional Registry of Anticoagulation Treatment (BI-006-IT)

NCT00317343 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-05-07

No results posted yet for this study

Summary

RIAPRE is a non-interventional registry to be settled in Italy with the purpose of collecting data on 600 cases of high risk elective percutaneous coronary intervention (PCI) patients treated with an anticoagulation regime different from unfractionated heparin in monotherapy. About thirty catheterization laboratories will co-operate in this activity. The long term outcome of patients will be taken into consideration. The availability of these data will allow for a better understanding of the therapeutic needs in this area.

Conditions

  • Coronary Disease

Interventions

DRUG

Bivalirudin (thrombin specific anticoagulant)

Percutaneous Coronary Intervention

Sponsors & Collaborators

  • Nycomed

    lead INDUSTRY

Principal Investigators

  • Nycomed Clinical Project Management · Headquarters

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2008-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00317343 on ClinicalTrials.gov